Optimization of HIV Care and Treatment
The DC CFAR supports research on the optimization of HIV care and treatment. Active areas of research include engagement and retention in care, barriers to care for highly impacted populations, mechanisms of aging and drug design and delivery.
Active NIH Funding
- Palliative Care in People Living with AIDS: Integrating into Standard of Care
-
4R01NR014052-05
Maureen Lyon, PhD
Children's National Medical Center - Role of PROBDNF and P75NTR in HIV-Mediated Axonal/Dendritic Degeneration
-
4R01NS079172-05
Italo Mocchetti, PhD
Georgetown University - Washington Women's Interagency HIV/AIDS Study
-
4U01AI034994-23
Seble Kassaye, MD
Georgetown University - PAR-1 signaling and HAND
-
4R01NS083410-04
Katherine Conant, MD
Georgetown University - Terry Beirn CPCRA clinical trials unit
-
5UM1AI069503-10
Virginia (Ginny) Kan, MD
Veterans Affairs Medical Center - DC Cohort
-
5UM1AI069503-10
Alan Greenberg, MD, MPH
The George Washington University - EVALUATING COMPANION DIAGNOSTICS TO THE ANAL PAP TEST TO IMPROVE PREDICTION OF AIN2+ IN HIV-INFECTED MSM
-
1R01CA203604-01A1
Jeanne Jordan, PhD
George Washington University - HAART-Mediated Cardiovascular Toxicity in HIV-1 Transgenic Rats: MG Protection
-
5R21HL125038-02
Ivan Tong Mak, PhD
The George Washington University - OPIOID WITHDRAWAL AND MICROGLIA: SYNERGISTIC EFFECT WITH HIV-MEDIATED NEURODEGENERATION?
-
1R21NS102121-01A1
Italo Mocchetti, PhD
Georgetown University - NEF AND NEUROAIDS: ROLE OF CHOLESTEROL METABOLISM IMPAIRMENT AND INFLAMMATION
-
1R01NS102163-01
Michael Bukrinsky, MD, PhD
The George Washington University